Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kull

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Medical Physics|August 27, 2005
Internal radionuclide therapy: the ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.
Nanoscale|July 6, 2017
Quantitative and correlative biodistribution analysis of <sup>89</sup>Zr-labeled mesoporous silica nanoparticles intravenously injected into tumor-bearing miceLarissa Kramer, Gordon Winter, Benjamin Baur, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analoguesBoris D Zlatopolskiy, Agnieszka Morgenroth, Elizaveta A Urusova, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2003
A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapyInga Buchmann, Thomas Kull, Gerhard Glatting, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Synthesis and biologic study of IV-14, a new ribonucleoside radiotracer for tumor visualizationBoris D Zlatopolskiy, Agnieszka Morgenroth, Falk H-G Kunkel, et al.
World Journal of Gastroenterology|April 8, 2016
Proposal of a computed tomography classification for hepatic alveolar echinococcosisTilmann Graeter, Wolfgang Kratzer, Suemeyra Oeztuerk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridineAgnieszka Morgenroth, Sandra Deisenhofer, Gerhard Glatting, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 4, 2011
New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitorsAgnieszka Morgenroth, Elizaveta A Urusova, Cornelia Dinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Medical Physics|August 27, 2005
Internal radionuclide therapy: the ULMDOS software for treatment planningGerhard Glatting, Michael Landmann, Thomas Kull, et al.
Nanoscale|July 6, 2017
Quantitative and correlative biodistribution analysis of <sup>89</sup>Zr-labeled mesoporous silica nanoparticles intravenously injected into tumor-bearing miceLarissa Kramer, Gordon Winter, Benjamin Baur, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analoguesBoris D Zlatopolskiy, Agnieszka Morgenroth, Elizaveta A Urusova, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2003
A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapyInga Buchmann, Thomas Kull, Gerhard Glatting, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2009
Synthesis and biologic study of IV-14, a new ribonucleoside radiotracer for tumor visualizationBoris D Zlatopolskiy, Agnieszka Morgenroth, Falk H-G Kunkel, et al.
World Journal of Gastroenterology|April 8, 2016
Proposal of a computed tomography classification for hepatic alveolar echinococcosisTilmann Graeter, Wolfgang Kratzer, Suemeyra Oeztuerk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Preferential tumor targeting and selective tumor cell cytotoxicity of 5-[131/125I]iodo-4'-thio-2'-deoxyuridineAgnieszka Morgenroth, Sandra Deisenhofer, Gerhard Glatting, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 4, 2011
New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitorsAgnieszka Morgenroth, Elizaveta A Urusova, Cornelia Dinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Pageof 2